Dear Sen-Jammers,

Tonight, when the March Madness buzzer sounds, so does your last chance to invest under our current valuation—and to secure a Fractional Royalty Right in what could be the most valuable anti-inflammatory platform since aspirin.

Sen-Jam is targeting massive markets with a scalable, multi-asset model disrupting how the trillion-dollar pharma industry thinks about inflammation.

We’re down to the wire:

✅ Only $500K in Royalty Rights left - thats just 100 investors at $5K+ each

✅ Valuation climbs after this round closes

If you've been on the sidelines, now’s the moment. In a volatile world, this may be one of the smartest bets you can make—a company built for resilience, upside, and purpose.

Don’t miss the buzzer. Don’t miss your stake.

INVEST NOW.

See you on the upside,

Jim